Current Information
 |
Click here to listen to Deborah Covington, DrPH, Senior Director, Registries and Epidemiology at Kendle address the latest issues on registries in an interview with Taren Grom, Editor, PharmaVOICE |
 |
Kendle manages more pregnancy registries than any other CRO, including the oldest and largest ongoing pregnancy exposure registry ever conducted. Click here to learn more |
Active Registries
Kendle's experience developing, implementing, and managing pregnancy registries is unsurpassed. We currently manage more pregnancy registries than any other CRO.
Below are links to our active pregnancy registry web sites for use by both patients and physicians.
Amevive® Pregnancy Exposure Registry
Antiretroviral Pregnancy Registry
Avonex® Pregnancy Exposure Registry
Betaseron® Pregnancy Registry
Bupropion Pregnancy Registry
Exenatide Pregnancy Registry
Global Gleevec/Glivec and Tasigna Pregnancy Exposure Registry
Lamotrigine Pregnancy Registry
Ribavirin Pregnancy Registry
Sumatriptan/Naratriptan/Treximet Pregnancy Registry
UCB AED Pregnancy Registry
Request Additional Information and Report
Amevive® Pregnancy Exposure Registry
Pregnant patients exposed to Amevive® within the 8 weeks prior to conception and during the pregnancy and who are still currently pregnant may contact the registry at:
Phone: 800-811-0104
Fax: 800-800-1052
Email: registries@kendle.com
Antiretroviral Pregnancy Registry
http://www.apregistry.com
Avonex® Pregnancy Exposure Registry
Pregnant patients exposed to Avonex® around the time of conception and during the first trimester of pregnancy and who are still currently pregnant may contact the registry at:
Phone: 800-811-0104
Fax: 800-800-1052
Email: registries@kendle.com
Betaseron® Pregnancy Registry
Pregnant patients or healthcare providers of pregnant patients exposed to Betaseron® at the time of conception (i.e., any time from the first day of the last menstrual period) and/or during pregnancy may contact the registry at:
Phone: 800-478-7049
Fax: 800-800-1052
Email: registries@kendle.com
Bupropion Pregnancy Registry
http://pregnancyregistry.gsk.com/bupropion.html
Additional forms are provided below:
Exenatide Pregnancy Registry
http://www.exenatidepregnancyregistry.com
Pregnant patients or health care providers of pregnant patients exposed to exenatide (BYETTA® injection or other formulations of exenatide) and/or one or more other non-insulin antidiabetic medications at the time of conception (i.e., on or after the first day of the last menstrual period) may contact the registry at:
Phone: 800-633-9081
Email: registries@kendle.com
Global Gleevec/Glivec Gleevec/Glivec and Tasigna Pregnancy Exposure Registry
http://www.tkipregnancyregistry.com
Health care providers of pregnant patients exposed to imatinib or nilotinib at any time during pregnancy and up to 6 months prior to conception may contact the registry at:
United States: 866-955-2762
Australia: 800.0980.77
Greece/Ireland/Sweden: 00.800.2714.5059
India: 080.0610.1099
Israel: 800.2714.5008
China/Japan/Taiwan: 800.0053.6353
Netherlands/Czech Republic/France/Belgium/Germany/Spain/UK/Russia/Poland/Italy/Bulgary: 800.2714.5008
Email: registries@kendle.com
Lamotrigine Pregnancy Registry
http://pregnancyregistry.gsk.com/lamotrigine.html
Additional forms are provided below:
Ribavirin Pregnancy Registry
http://www.ribavirinpregnancyregistry.com
Sumatriptan/Naratriptan/Treximet Pregnancy Registry
http://pregnancyregistry.gsk.com/sumatriptan.html
Additional forms are provided below:
UCB AED Pregnancy Registry
Pregnant patients or health care providers of pregnant patients who have been exposed to Keppra® or other UCB antiepileptic drug (AED) prior to conception and during pregnancy may contact the UCB AED Pregnancy Registry (formerly, the Keppra Pregnancy Registry) via
phone: 1-888-537-7734 (1-888-KEP-PREG)
fax: 1-800-800-1052
Email: registries@kendle.com
Please reference www.keppra.com for prescribing information.
|
